PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-May-2022 insitro Announces Formation of Scientific Advisory Board to Support Platform and Pipeline Advancement Businesswire
02-May-2022 Teva Announces Settlement with Lupin Resolving AUSTEDO® (deutetrabenazine) Patent Dispute Businesswire
02-May-2022 RHINOstic™ Automated Nasal Swab Earns Health Canada COVID-19 Interim Order No. 2 Medical Device Authorization Businesswire
02-May-2022 VistaGen Appoints Reid Adler as Chief Legal Officer Businesswire
02-May-2022 Meitheal Pharmaceuticals Announces Membership in The Association for Accessible Medicines Businesswire
02-May-2022 Arrowhead Pharmaceuticals Appoints Victoria Vakiener to Board of Directors Businesswire
02-May-2022 DTx Pharma Announces Appointment of Kathie M. Bishop to its Board of Directors Businesswire
02-May-2022 Santen’s Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% Now Available for the Treatment of Vernal Keratoconjunctivitis in Children and Adults in the United States Businesswire
02-May-2022 Precision BioSciences to Report First Quarter 2022 Financial Results on May 9, 2022 Businesswire
02-May-2022 Antibe Therapeutics Announces Strategic Sale of Citagenix Subsidiary Businesswire
02-May-2022 Blue Spark Technologies Announces Appointment of John DeFord, Ph.D. to its Board of Directors Businesswire
02-May-2022 Enanta Pharmaceuticals to Host Conference Call on May 9 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2022 Businesswire
02-May-2022 Can-Fite’s CEO to Present Namodenoson’s Efficacy in Liver Cancer as Expert Speaker at the Adenosine Pathway Targeted Cancer Immunotherapy Summit Businesswire
02-May-2022 Akanda Completes Acquisition of Holigen, Advancing Cannabis Leadership Position in Europe, the Middle East and Africa (EMEA) Businesswire
02-May-2022 Sage Therapeutics and Biogen Initiate Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for Zuranolone for the Potential Treatment of Major Depressive Disorder (MDD) Businesswire
02-May-2022 Energous Adds Three Industry Veterans to Board of Advisors as Company Focuses on Powering the Growing Industrial and Retail Internet of Things Ecosystem Businesswire
02-May-2022 FSD Pharma Announces Engagement with Tekkfund Capital and Share Issuance to Crystal Research Associates Businesswire
02-May-2022 OSE Immunotherapeutics Announces New European Patent Granted Covering CLEC-1, Novel Myeloid Immune Checkpoint Target For Cancer Immunotherapy Businesswire
02-May-2022 NEXEL Earns the First ISO/IEC 17025:2017 Accreditation for iPSC-derived Cardiomyocyte-based Cardiac Safety Testing Businesswire
02-May-2022 Europäische Kommission erteilt UPLIZNA® (Inebilizumab) die Zulassung zur Behandlung von Erwachsenen mit Neuromyelitis-optica-Spektrum-Erkrankungen (NMOSD) Businesswire